-
-
-
-
-
-
-
Clearmind Medicine reports positive safety data from CMND-100 trial
-
-
-
-
-
-
-
Veradermics completes enrollment in second Phase 3 trial for hair loss drug
-
-
-
-
-
-
-
Median Technologies receives FDA clearance for AI lung cancer screening device
-
-
-
-
-
-
-
TG Therapeutics presents BRIUMVI data at multiple sclerosis forum
-
-
-
-
-
-
-
Iovance reports 52% response rate for Amtagvi in early melanoma treatment
-
-
-
-
-
-
-
Telomir Pharmaceuticals reports cellular data on metal modulation mechanism
-
-
-
-
-
-
-
Alvotech reports positive results for Entyvio biosimilar study
-
73,955 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

